Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

NCT: NCT06963775 · NOT_YET_RECRUITING

NCT IDNCT06963775
StatusNOT_YET_RECRUITING
Start Date2026-07-15
Completion2030-07-31
SponsorRamon Diaz-Arrastia (OTHER)
First posted
Last updated

Brief Summary

Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).

Frequently Asked Questions

What is Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials?

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials is a clinical trial registered under NCT06963775. Current status: NOT_YET_RECRUITING.

What is the status of NCT06963775?

The current status of NCT06963775 (Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials) is: NOT_YET_RECRUITING.

When did Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials start?

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials started on 2026-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑